The shares sold earlier this month — on Aug. 5 — were sold at $79.81 per share. This time, Ms. Stryker sold her shares for $80.69 per share with a total transaction valued at more than $1.1 million. She now directly owns 174,605 shares of the company’s stock, valued at $14 million.
In the month of July, Ms. Stryker sold 21,000 shares in two separate transactions, totaling more than $1.7 million. The company’s stock opened at $80.99 per share on Aug. 18 and has a market cap of $30.79 billion.
The company’s second quarter net sales grew 6.8 percent to $2.4 billion, with acquisitions accounting for 2.1 percent of the company’s growth.
More articles on orthopedic devices:
52 spine, orthopedic devices receive FDA 510(k) clearance in July
Smith & Nephew’s new sales model to lower costs: Is it sustainable?
Stryker may have global hip lawsuits settlement soon
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
